Cargando…

Microangiopathy in Ocular Sarcoidosis Using Fluorescein Gonio and Fundus Angiography from Diagnostic and Therapeutic Aspects

In this retrospective study, we investigated vascular abnormalities in sarcoidosis using fluorescein gonioangiography (FGA) to detect angle neovascularization (ANV), fundus fluorescein angiography (FFA), and pathological specimens from the aspects of microangiopathy. In 57 sarcoidosis patients, clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamanaka, Teruhiko, Akabane, Noriko, Sakurai, Tetsuro, Ikushima, Soichiro, Kumasaka, Toshio, Takemura, Tamiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823990/
https://www.ncbi.nlm.nih.gov/pubmed/33379396
http://dx.doi.org/10.3390/diagnostics11010039
_version_ 1783639968196853760
author Hamanaka, Teruhiko
Akabane, Noriko
Sakurai, Tetsuro
Ikushima, Soichiro
Kumasaka, Toshio
Takemura, Tamiko
author_facet Hamanaka, Teruhiko
Akabane, Noriko
Sakurai, Tetsuro
Ikushima, Soichiro
Kumasaka, Toshio
Takemura, Tamiko
author_sort Hamanaka, Teruhiko
collection PubMed
description In this retrospective study, we investigated vascular abnormalities in sarcoidosis using fluorescein gonioangiography (FGA) to detect angle neovascularization (ANV), fundus fluorescein angiography (FFA), and pathological specimens from the aspects of microangiopathy. In 57 sarcoidosis patients, clinical data was reviewed by dividing the cases into three groups (Group I: histologically diagnosed; Group II: positive bilateral hilar lymphadenopathy (BHL); Group III: negative BHL). The FFA, FGA, and pathological examination data in the autopsy eyes and trabeculectomy specimens were investigated. FGA and FFA detected ANV (91%) and nodule-associated abnormalities (87%), respectively. No intraocular pressure (IOP) elevation was observed after continuous topical betamethasone, except in the steroid responder group. Maximum IOP had significant correlation with nodules in the angle (p = 0.02696) and visual field defect (p = 0.0151). Granulomas adjacent to blood vessels, including the Schlemm’s canal, and thickening of the retinal blood vessel wall caused occlusion of those vessels. Photocoagulation was required for retinal tears (14%) and the retinal blood vessel occlusion (7%). Suppression of IOP elevation via continuous topical betamethasone may be important to avoid irreversible outflow-route changes and optic-nerve damage, and the concept of microangiopathy in ocular sarcoidosis may be important for understanding the proper treatment of serious complications.
format Online
Article
Text
id pubmed-7823990
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78239902021-01-24 Microangiopathy in Ocular Sarcoidosis Using Fluorescein Gonio and Fundus Angiography from Diagnostic and Therapeutic Aspects Hamanaka, Teruhiko Akabane, Noriko Sakurai, Tetsuro Ikushima, Soichiro Kumasaka, Toshio Takemura, Tamiko Diagnostics (Basel) Article In this retrospective study, we investigated vascular abnormalities in sarcoidosis using fluorescein gonioangiography (FGA) to detect angle neovascularization (ANV), fundus fluorescein angiography (FFA), and pathological specimens from the aspects of microangiopathy. In 57 sarcoidosis patients, clinical data was reviewed by dividing the cases into three groups (Group I: histologically diagnosed; Group II: positive bilateral hilar lymphadenopathy (BHL); Group III: negative BHL). The FFA, FGA, and pathological examination data in the autopsy eyes and trabeculectomy specimens were investigated. FGA and FFA detected ANV (91%) and nodule-associated abnormalities (87%), respectively. No intraocular pressure (IOP) elevation was observed after continuous topical betamethasone, except in the steroid responder group. Maximum IOP had significant correlation with nodules in the angle (p = 0.02696) and visual field defect (p = 0.0151). Granulomas adjacent to blood vessels, including the Schlemm’s canal, and thickening of the retinal blood vessel wall caused occlusion of those vessels. Photocoagulation was required for retinal tears (14%) and the retinal blood vessel occlusion (7%). Suppression of IOP elevation via continuous topical betamethasone may be important to avoid irreversible outflow-route changes and optic-nerve damage, and the concept of microangiopathy in ocular sarcoidosis may be important for understanding the proper treatment of serious complications. MDPI 2020-12-28 /pmc/articles/PMC7823990/ /pubmed/33379396 http://dx.doi.org/10.3390/diagnostics11010039 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hamanaka, Teruhiko
Akabane, Noriko
Sakurai, Tetsuro
Ikushima, Soichiro
Kumasaka, Toshio
Takemura, Tamiko
Microangiopathy in Ocular Sarcoidosis Using Fluorescein Gonio and Fundus Angiography from Diagnostic and Therapeutic Aspects
title Microangiopathy in Ocular Sarcoidosis Using Fluorescein Gonio and Fundus Angiography from Diagnostic and Therapeutic Aspects
title_full Microangiopathy in Ocular Sarcoidosis Using Fluorescein Gonio and Fundus Angiography from Diagnostic and Therapeutic Aspects
title_fullStr Microangiopathy in Ocular Sarcoidosis Using Fluorescein Gonio and Fundus Angiography from Diagnostic and Therapeutic Aspects
title_full_unstemmed Microangiopathy in Ocular Sarcoidosis Using Fluorescein Gonio and Fundus Angiography from Diagnostic and Therapeutic Aspects
title_short Microangiopathy in Ocular Sarcoidosis Using Fluorescein Gonio and Fundus Angiography from Diagnostic and Therapeutic Aspects
title_sort microangiopathy in ocular sarcoidosis using fluorescein gonio and fundus angiography from diagnostic and therapeutic aspects
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823990/
https://www.ncbi.nlm.nih.gov/pubmed/33379396
http://dx.doi.org/10.3390/diagnostics11010039
work_keys_str_mv AT hamanakateruhiko microangiopathyinocularsarcoidosisusingfluoresceingonioandfundusangiographyfromdiagnosticandtherapeuticaspects
AT akabanenoriko microangiopathyinocularsarcoidosisusingfluoresceingonioandfundusangiographyfromdiagnosticandtherapeuticaspects
AT sakuraitetsuro microangiopathyinocularsarcoidosisusingfluoresceingonioandfundusangiographyfromdiagnosticandtherapeuticaspects
AT ikushimasoichiro microangiopathyinocularsarcoidosisusingfluoresceingonioandfundusangiographyfromdiagnosticandtherapeuticaspects
AT kumasakatoshio microangiopathyinocularsarcoidosisusingfluoresceingonioandfundusangiographyfromdiagnosticandtherapeuticaspects
AT takemuratamiko microangiopathyinocularsarcoidosisusingfluoresceingonioandfundusangiographyfromdiagnosticandtherapeuticaspects